Nasdaq:US$34.13 (+0.27) | HKEX:HK$55.55 (+0.55) | AIM:£5.14 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2011

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models